Skip to main content

Facioscapulohumeral Muscular Dystrophy

  • Reference work entry
  • First Online:
  • 115 Accesses

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is the third most common neuromuscular disorder after Duchenne muscular dystrophy and myotonic dystrophy (Upadhyaya and Cooper 2002). It is characterized by progressive weakness and atrophy of the facial and shoulder girdle muscles. The other muscles are also involved. Its prevalence is estimated to be 1 in 20,000 in Europe (Lunt and Harper 1991).

This is a preview of subscription content, log in via an institution.

References

  • Bakker, E., Van der Wielen, M. J., Voorhoeve, E., et al. (1996). Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: Diagnostic approach for sporadic and familial cases. Journal of Medical Genetics, 33, 29–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ciafaloni, E., Pressman, E. K., Lori, A. M., et al. (2006). Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy. Neurology, 67, 1887–1889.

    Article  CAS  PubMed  Google Scholar 

  • Eger, K., Jordan, B., Habermann, S., et al. (2010). Beevor’s sign in facioscapulohumeral muscular dystrophy: An old sign with new implications. Journal of Neurology, 257, 436–438.

    Article  PubMed  Google Scholar 

  • Eggers, S., Passos-Bueno, M. R., & Zatz, M. (1993). Facioscapulohumeral muscular dystrophy: Aspects of genetic counselling, acceptance of preclinical diagnosis, and fitness. Journal of Medical Genetics, 30, 589–592.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Felice, K. J., & Moore, S. A. (2001). Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion. Muscle & Nerve, 24, 352–356.

    Article  CAS  Google Scholar 

  • Fitzsimons, R. B. (1999). Facioscapulohumeral muscular dystrophy. Current Opinion in Neurology, 12, 501–511.

    Article  CAS  PubMed  Google Scholar 

  • Kissel, J. T. (1999). Facioscapulohumeral dystrophy. Seminars in Neurology, 19, 35–43.

    Article  CAS  PubMed  Google Scholar 

  • Köhler, J., Rupilius, B., Otto, M., et al. (1996). Germline mosaicism in 4q35 facioscapulohumeral muscular dystrophy (FSHD1A) occurring predominantly in oogenesis. Human Genetics, 98, 485–490.

    Article  PubMed  Google Scholar 

  • Laforet, P., de Toma, C., Eymard, B., et al. (1998). Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology, 51, 1454–1456.

    Article  CAS  PubMed  Google Scholar 

  • Lemmers, R.J.L.F., & van der Maarel, S.M. (2014). Facioscapulohumeral muscular dystrophy. GeneReviews. Updated 20 Mar 2014. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1443/

  • Lemmers, R. J., Wohlgemuth, M., van der Gaag, K. J., et al. (2007). Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. American Journal of Human Genetics, 81, 884–894.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lunt, P. W., & Harper, P. S. (1991). Genetic counseling in facioscapulohumeral muscular dystrophy. Journal of Medical Genetics, 28, 655–664.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lunt, P. W., Jardine, P. E., Koch, M., et al. (1995). Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy. Muscle & Nerve, 2, S103–S109.

    Article  CAS  Google Scholar 

  • Orrell, R. W., Tawil, R., Forrester, J., et al. (1999). Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology, 52, 1822–1826.

    Article  CAS  PubMed  Google Scholar 

  • Padberg, G. W., & van Engelen, B. G. M. (2009). Facioscapulohumeral muscular dystrophy. Current Opinion in Neurology, 22, 539–542.

    Article  PubMed  Google Scholar 

  • Ricci, E., Galluzzi, G., Deidda, G., et al. (1999). Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q25 locus and clinical phenotype. Annals of Neurology, 45, 751–757.

    Article  CAS  PubMed  Google Scholar 

  • Rudnik-Schoneborn, S., Glauner, B., Rohrig, D., et al. (1997). Obstetric aspects in women with facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and congenital myopathies. Archives of Neurology, 54, 888–894.

    Article  CAS  PubMed  Google Scholar 

  • Sacconi, S., Lemmers, R. J. L. F., Balog, J., et al. (2013). The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. American Journal of Human Genetics, 93, 744–751.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sacconi, S., Salviati, L., & Desnuelle, C. (2015). Facioscapulohumeral dystrophy. Biochimica et Biophysica Acta, 1852, 607–614.

    Article  CAS  PubMed  Google Scholar 

  • Sripathi, N. (2014). Facioscapulohumeral dystrophy. eMedicine from WebMD. Updated 16 Oct 2014. Available at: http://emedicine.medscape.com/article/1176126-overview

  • Statland, J., & Tawil, R. (2014). Facioscapulohumeral dystrophy. Neurologic Clinics, 32, 721–728.

    Article  PubMed  PubMed Central  Google Scholar 

  • Statland, J., Donlin-smith, C. M., Tapscott, S. J., et al. (2014). Multiplex screen of serum biomarkers in Facioscapulohumeral dystrophy. Journal of Neuromuscular Disorders, 1, 181–190.

    Google Scholar 

  • Tawil, R., & Van Der Maarel, S. M. (2006). Facioscapulohumeral muscular dystrophy. Muscle & Nerve, 34, 1–15.

    Article  CAS  Google Scholar 

  • Tawil, R., Forrester, J., Griggs, R. C., et al. (1996). Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Annals of Neurology, 39, 744–748.

    Article  CAS  PubMed  Google Scholar 

  • Tawil, R., Figlewicz, D. A., Griggs, R. C., et al. (1998). Facioscapulohumeral dystrophy: A distinct regional myopathy with a novel molecular pathogenesis. FSH consortium. Annals of Neurology, 43, 279–282.

    Article  CAS  PubMed  Google Scholar 

  • Tawil, R., van der Maarel, S., Padberg, G. W., et al. (2010). 171st ENMC International Workshop: Standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscular Disorders, 20, 471–475.

    Article  PubMed  Google Scholar 

  • Tawil, R., Kissel, J. T., Heatwole, C., et al. (2015). Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy. Neurology, 85, 357–364.

    Article  PubMed  PubMed Central  Google Scholar 

  • Upadhyaya, M., & Cooper, D. N. (2002). Molecular diagnosis of facioscapulohumeral muscular dystrophy. Expert Review of Molecular Diagnostics, 2, 160–171.

    Article  CAS  PubMed  Google Scholar 

  • Upadhyaya, M., Maynard, J., Osborn, M., et al. (1995). Germinal mosaicism in facioscapulohumeral muscular dystrophy (FSHD). Muscle & Nerve, 2, S45–S49.

    Article  CAS  Google Scholar 

  • Upadhyaya, M., MacDonald, M., & Ravine, D. (1999). Prenatal diagnosis for facioscapulohumeral muscular dystrophy (FSHD). Prenatal Diagnosis, 19, 959–965.

    Article  CAS  PubMed  Google Scholar 

  • van Deutekom, J. C., Bakker, E., Lemmers, R. J., et al. (1996). Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: Implications for genetic counselling and etiology of FSHD1. Human Molecular Genetics, 5, 1997–2003.

    Article  PubMed  Google Scholar 

  • Wohlgemuth, M., van der Kooi, E. L., van Kesteren, R. G., et al. (2004). Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology, 63, 176–178.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this entry

Cite this entry

Chen, H. (2017). Facioscapulohumeral Muscular Dystrophy. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2401-1_84

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2401-1_84

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2400-4

  • Online ISBN: 978-1-4939-2401-1

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics